Approval of a cheap version of HIV-prevention shot lenacapavir raises hopes in low-income countries
The US FDA has approved a generic version of lenacapavir, a twice-a-year shot to prevent HIV, making it available inexpensively and more quickly in 120 low- and middle-income countries. This approval is a significant step towards ending AIDS. Dr Reddy's obtained tentative FDA approval for the generic version. The medication, developed by Gilead Sciences, will help increase access to HIV prevention in lower-income countries.
Listen to Live Briefing
Real-time synthesized voice briefing · Live Feeds Desk
- ✓ The US FDA has approved a generic version of lenacapavir, a twice-a-year shot to prevent HIV.
- ✓ The generic version of lenacapavir will be available inexpensively and more quickly in 120 low- and middle-income countries.
- ✓ Dr Reddy's obtained tentative FDA approval for the generic version of lenacapavir.
What changed
The US FDA has granted tentative approval to Dr Reddy's for a generic version of lenacapavir, marking a significant milestone in making the HIV prevention shot available in low-income countries.
Live updates
-
US FDA Approves Generic HIV Prevention Shot Lenacapavir
The US FDA has approved a generic version of lenacapavir, a twice-a-year shot to prevent HIV, making it available inexpensively and more quickly in 120 low- and middle-income countries. This approval is a significant step towards ending AIDS. Dr Reddy's obtained tentative FDA approval for the generic version. The medication, developed by Gilead Sciences, will help increase access to HIV prevention in lower-income countries.
Why it matters
The approval of lenacapavir is crucial in the fight against HIV, particularly in low-income countries where access to expensive medication is limited. According to the World Health Organization, there were 39 million people living with HIV globally in 2022. The availability of a cheap, generic version of lenacapavir is expected to significantly increase the number of people accessing HIV prevention services.
What is confirmed
- The US FDA has approved a generic version of lenacapavir, a twice-a-year shot to prevent HIV.
- The generic version of lenacapavir will be available inexpensively and more quickly in 120 low- and middle-income countries.
- Dr Reddy's obtained tentative FDA approval for the generic version of lenacapavir.
What to watch next
- Availability and pricing of lenacapavir in low-income countries
- Impact of lenacapavir on HIV prevention rates globally
- Potential challenges in distributing lenacapavir in low-income countries
confidence 100%Sources used for this update (13)
- AP News — Approval of a cheap version of HIV-prevention shot lenacapavir raises hopes in low-income countries
- Reuters — Dr Reddy's gets tentative US FDA nod for generic HIV prevention
- STAT — FDA OKs generic HIV prevention shot, widening access for lower-income countries
- Unitaid — U.S. FDA approves first generic injectable lenacapavir for HIV prevention
- RAPS — Recon: FDA approves generic lenacapavir intended for lower income countries; EMA to review Lundbeck's Deanxit for reported serious side effects
- The Independent — US approves cheap generic version of breakthrough HIV prevention jab – in major step towards ending Aids
- WSAV-TV — Promising new HIV-prevention drug is hard to find where it’s most needed, in places like Uganda
- www.yahoo.com — Approval of a cheap version of HIV-prevention shot ... - Yahoo
- jamaica-gleaner.com — FDA approval of cheap version of HIV-prevention shot ...
- abcnews.com — Approval of cheap version of HIV-prevention shot raises hopes ...
- github.com — Andorina-WhatsApp-Agent-for-Hermes/versions/v1.5.2-Beta3 ... -...
- github.com — Andorina-WhatsApp-Agent-for-Hermes/versions/V1.0.3-OUT-DEVICE-TES...
Community Sentiment: How do you assess this situation?
Voice your perspective · Real-time aggregated sentiment from the Live Feeds community